Dr David White, inventor of Goodair Nosebuds, talks to reporter Tom Raynel about the inspiration behind his invention and how its applications could go global.

What is Goodair?
Goodair is a startup focused on developing, designing and manufacturing fibre acoustic nasal breathing devices. These “nosebuds” are an alternative way to treat nasal congestion — a major problem for many people, especially during allergy season.

Dr White explains they’re also looking at other applications where nasal breathing can influence wellbeing and health.

What inspired you to make the nosebuds?
The idea came from earlier research into a new type of CPAP machine for treating sleep apnea. They discovered that airflow through the nose could influence sleep stages, possibly due to a gas naturally produced in the sinuses called nitric oxide.

Experimenting with acoustic vibrations and airflow led to the concept of nosebuds — portable devices that amplify nitric oxide and help with nasal decongestion.

How did you commercialise the idea?
The commercialisation was supported by AUT Ventures (the commercial arm of Auckland University of Technology). Goodair’s CEO Kerry McMaster identified the large nasal congestion market (estimated at US$30 billion) and encouraged Dr White to initially focus on that rather than purely medical applications.

Their first shipment sold out within two days, and they’re producing more stock.

Future plans
Goodair is looking to expand internationally, including into Australia and Northern Hemisphere markets, and explore additional applications like sleep support and possibly mood regulation.

Advice for entrepreneurs
Dr White suggests connecting with the right people and engaging with the community. Working in isolation limits progress — there are many people willing to help with advice.